000 01489 a2200445 4500
005 20250515055940.0
264 0 _c20070417
008 200704s 0 0 eng d
022 _a1093-507X
024 7 _a10.1089/dis.2006.626
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLefebvre, Patrick
245 0 0 _aThe economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.
_h[electronic resource]
260 _bDisease management : DM
_cFeb 2007
300 _a37-45 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aComorbidity
650 0 4 _aCost Savings
650 0 4 _aDisease Progression
650 0 4 _aEpoetin Alfa
650 0 4 _aErythropoietin
_xeconomics
650 0 4 _aGlomerular Filtration Rate
650 0 4 _aHematinics
_xeconomics
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xeconomics
650 0 4 _aMedicare
650 0 4 _aModels, Economic
650 0 4 _aRecombinant Proteins
650 0 4 _aRenal Dialysis
_xeconomics
650 0 4 _aRetrospective Studies
650 0 4 _aTime Factors
650 0 4 _aUnited States
700 1 _aDuh, Mei Sheng
700 1 _aMody, Samir H
700 1 _aBookhart, Brahim
700 1 _aPiech, Catherine Tak
773 0 _tDisease management : DM
_gvol. 10
_gno. 1
_gp. 37-45
856 4 0 _uhttps://doi.org/10.1089/dis.2006.626
_zAvailable from publisher's website
999 _c16868295
_d16868295